For patients with immune-mediated inflammatory diseases, CVD mortality decreased from 1999 to 2020, but sex disparities persist.

AI tools are effective for detecting left ventricular systolic dysfunction among women of reproductive age seen in primary care.

Gender-affirming hormone therapy was associated with a significant reduction in moderate to severe depression among TGD adults in the US.

OpenAI has unveiled a large dataset to help test how well artificial intelligence models answer health care questions.

Topline data were announced from a phase 3 trial evaluating olezarsen in patients with moderate hypertriglyceridemia with or at risk for ASCVD.

Inhaled insulin was noninferior to usual care in glycemic control outcomes after 17 weeks among patients with type 1 diabetes.

Between 1999 and 2019 in the US, deaths related to hypertrophic cardiomyopathy decreased, but then significantly increased during the COVID-19 pandemic.

Following discharge for COVID-19 hospitalization, county-level social deprivation does not affect long-term cardiovascular risk.

Adolescent hyperglycemia and worsening insulin resistance are associated with an increased risk for worsening structural and functional cardiac damage.

The FDA has approved Optison for use in pediatric patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricle endocardial borders.

Glucagon-like peptide-1 receptor agonists are tied to a reduction in alcohol intake in patients being treated for obesity.

Researchers have found that, among nulliparous patients, hypertensive disorders of pregnancy significantly increase risk for incident atrial fibrillation.